Melanoma Reagents | abinScience

Inicio > Productos Destacados > Oncology Research > Melanoma

960 resultados de producto para "Melanoma"

Opciones+

Opciones

Confirmar

Tipos de productos

0 seleccionado

Assay Kit (419)

Proteins (75)

Biosimilars (1)

Research Biosimilar (157)

Antibodies (298)

Stable Cell Lines (1)
Sistema de expresión

0 seleccionado

E. coli (35)

Mammalian Cells (186)

HEK293T (1)
Objetivo

0 seleccionado

Losatuxizumab (1)

Afasevikumab (1)

β-D-Glucan (1)

Suptavumab (1)

B7-H1 / PD-L1 / CD274 & CD3E (1)

Epcoritamab (1)

F/Fusion glycoprotein F0 (5)

Letolizumab (1)

dsRNA (1)

Ibalizumab (1)

Ianalumab (1)

Tocilizumab (3)

Spike Protein (Trimer) (2)

Dupilumab (3)

Inclacumab (1)

IL1RL1/ST2 (1)

VSIR/VISTA & CD274/PD-L1 (1)

Cergutuzumab (1)

cGMP (1)

Lorvotuzumab (1)

RBD (Gamma) (1)

MITF (1)

Cetrelimab (1)

DCT (2)

Otilimab (1)

Navicixizumab (1)

VEGFA & B7-H1 / PD-L1 / CD274 (1)

Zagotenemab (1)

gE/Envelope glycoprotein E (1)

Tarextumab (1)

Lodelcizumab (1)

PD-L1 & VEGF (1)

Figitumumab (1)

A35R (5)

Farletuzumab (1)

Ustekinumab (3)

CD79B (2)

p-Tyr (1)

Icrucumab (1)

CD152/CTLA4 (86)

CD274/PD-L1 & TGFBR2 (1)

CD279/PD-1 & CD152/CTLA4 (4)

CD274/PD-L1 & CD3E (1)

Mirvetuximab (1)

B6R/SL-159 (1)

CD274/PD-L1/B7-H1 (5)

Necitumumab (1)

Bimekizumab (1)

Zenocutuzumab (1)

Glofitamab (1)

Guselkumab (3)

ATP7B (1)

Benufutamab (1)

Amatuximab (1)

Tregalizumab (1)

PD-L1 & TGF-Beta (1)

NP/Nucleocapsid (5)

dsDNA (1)

Astegolimab (1)

Adalimumab (3)

Tiragolumab (2)

Labetuzumab (1)

Obiltoxaximab (1)

BSA (1)

RBD (E484K) (1)

Alacizumab (1)

Faricimab (1)

Nivolumab (3)

Atezolizumab (3)

Sotrovimab (1)

MLANA (4)

Edrecolomab (1)

gD/Envelope glycoprotein D (1)

Urelumab (1)

Canakinumab (1)

LAG-3 & PD-1 (1)

Ganitumab (1)

A29L (6)

Oxelumab (1)

TRP-1 & CD3e (1)

Omalizumab (2)

S100P (1)

CD223/LAG3 & CD152/CTLA4 (1)

S100A10 (4)

Lintuzumab (1)

CD274/PD-L1 & CD47/MER6 (1)

CD274/PD-L1 & SLT-Ia (1)

CD80/B7-1 (20)

Teprotumumab (1)

IL6 (1)

Bevacizumab (3)

SARS-CoV-2 Neutralization Antibody (3)

Ivuxolimab (1)

PDL1 & VEGF (1)

Panitumumab (3)

Ixekizumab (1)

Siltuximab (3)

Suvizumab (1)

CD47/MER6 & PDCD1 / PD-1 & CD137/4-1BB/TNFRSF9 (1)

Ibritumomab (1)

RBD (Omicron/BA.4/BA.5) (1)

CD278/ICOS (1)

Itolizumab (1)

TPP15 (1)

Anetumab (1)

Zanolimumab (1)

Blosozumab (1)

Lacnotuzumab (1)

Iscalimab (1)

Olaratumab (1)

Glycoprotein (5)

PMEL17/ME20M (9)

Protein A (1)

Tisotumab (1)

RBD (Kappa) (1)

Ramucirumab (1)

Nesvacumab (1)

Pembrolizumab (3)

mitF/aspF1 (1)

Milatuzumab (1)

Avelumab (3)

Befovacimab (1)

Casirivimab (1)

Bimagrumab (1)

gC/Envelope glycoprotein C (1)

Utomilumab (1)

Gevokizumab (1)

Tezepelumab (1)

CD47/MER6 & CD274/PD-L1 (2)

S100A16 (1)

HLA-A2-peptide (TDQVPFSV) Complex (1)

Ieramilimab (1)

CD274/PD-L1 & VEGFA (1)

TYRP1 (3)

CD19 & PD-L1 & CD3E & CD137 (1)

S100A9 (4)

Asp f 1/mitF (1)

CD274/PD-L1 & CD134/OX40 (1)

CD274/PD-L1 & CD28 & CD152/CTLA4 (1)

CD20/MS4A1 (3)

Etanercept (3)

Brolucizumab (1)

RBD (Omicron/BA.5) (3)

Pogalizumab (1)

Serclutamab (1)

Remtolumab (1)

Clazakizumab (1)

Mosunetuzumab (1)

TPP17 (1)

Conatumumab (1)

Romosozumab (1)

TYR (1)

Romiplostim (2)

Tovetumab (1)

M/Matrix protein (2)

CD3E (1)

Belantamab (1)

PD-L1 / VEGF-A (1)

Certolizumab (2)

Enoblituzumab (1)

Cabiralizumab (1)

Gremubamab (1)

Human β Amyloid (1-42) (1)

RBD (Delta Plus) (1)

Spike glycoprotein (RBD) (1)

Vanucizumab (1)

Sintilimab (1)

Glycoprotein G (2)

Durvalumab (3)

CD80&IL2 (1)

Concizumab (1)

Imdevimab (1)

CD117/KIT (24)

Rolinsatamab (1)

gC/UL44 (1)

Magrolimab (1)

Sarilumab (2)

CD152/CTLA4 & CD279/PD-1 (1)

HLA-A2-peptide (ITDQVPFSV) Complex (4)

EGFR & CD3E & PD-L1 & 4-1BB (1)

CD366/TIM-3 & CD274/PD-L1 (1)

TRP-1 & CD47/MER6 (1)

CD274/PD-L1 & CD279/PD-1 (1)

Oleclumab (1)

IDO1 (2)

CD366/TIM-3 & CD279/PD-1 (2)

Basiliximab (1)

Elezanumab (1)

Apamistamab (1)

Ranibizumab (3)

NP/Nucleoprotein (3)

Tavolimab (1)

Secukinumab (2)

Imlifidase (5)

Olokizumab (1)

Foravirumab (1)

CD47/MER6 & CD274/PD-L1/B7-H1 (2)

Ocaratuzumab (1)

Elotuzumab (1)

Cusatuzumab (1)

TPP47 (1)

Drozitumab (1)

Ontamalimab (1)

Eldelumab (1)

Sacituzumab (1)

Eculizumab (3)

Varlilumab (1)

Tirzepatide (2)

gp100 peptide-HLA Complex (1)

Teclistamab (1)

Mirzotamab (1)

CD223 (1)

Emactuzumab (1)

M1R (5)

Human β Amyloid (1-40) (1)

Imalumab (1)

Semaglutide (2)

Ascrinvacumab (1)

TFF3 (1)

Tislelizumab (1)

Disitamab (1)

Pacmilimab (1)

TDP2 (1)

Marstacimab (1)

Daratumumab (3)

gD/US6 (1)

Rituximab (1)

HLA-A2-peptide (YLEPGPVT) Complex (4)

Calprotectin (S100A8/9) (3)

BRAF/B-Raf (5)

Mavezelimab (1)

CD137/4-1BB & CD274/PD-L1 (3)

TRP-1 & CD134/OX40 (1)

CD274/PD-L1 & TGFBR2/TGFR-2 (1)

CD80/B7-1 & CD86/B7-2 (2)

S100A11 (2)

US8/gE (1)

Sibrotuzumab (1)

Fluorescein & CD274/PD-L1 (1)

Camidanlumab (1)

Mazdutide (2)

RBD (6)

Varisacumab (1)

RBD (Omicron/JN.1) (1)

Lirilumab (1)

CTLA4 & PD1 (2)

Tesidolumab (1)

Sirukumab (1)

Rafivirumab (1)

cAMP (1)

RBD (WT) (1)

Vorsetuzumab (1)

G/Major surface glycoprotein G (1)

Lexatumumab (1)

Mirikizumab (2)

PDL1 (6)

Aflibercept (1)

Ipilimumab (2)

GP/Envelope glycoprotein (4)

T3E (1)

Golimumab (3)

Omburtamab (1)

TAU pT181 (1)

Evolocumab (1)

EPO/Erythropoietin (1)

Lupartumab (1)

Toripalimab (1)

Exenatide acetate (2)

Pertuzumab (3)

CD137/4-1BB/TNFRSF9& CD274/PD-L1/B7-H1 (1)

Denosumab (3)

CD175/Tn (10)

S100A6 (1)

Abatacept (1)

HLA-A2-peptide (KTWGQYWQV) Complex (2)

Favezelimab (1)

CD86/B7-2 (26)

CD152/CTLA4 & CD274/PD-L1 (1)

Zampilimab (1)

NRAS (2)

CD47/MER6 & PDCD1 / PD-1 / CD279 (1)

Obinutuzumab (2)

Cetuximab (3)

Ifabotuzumab (1)

CD366/HAVCR2/TIM-3 (4)

Spike glycoprotein E2 (2)

Simlukafusp Alfa (1)

LAG3 & PD-1 (1)

Daclizumab (1)

Enfortumab (1)

Emibetuzumab (1)

RBD (Delta) (3)

FLT1/VEGFR1 & CD274/PD-L1 (1)

RBD (Omicron/KP.2) (1)

Tibulizumab (1)

Ziltivekimab (1)

VASH2/Vasohibin-2 (1)

Carlumab (1)

RBD (Alpha) (1)

N/Nucleoprotein (1)

Tigatuzumab (1)

Glembatumumab (1)

Lenzilumab (1)

Semorinemab (1)

Talacotuzumab (1)

S100A5 (4)

Tremelimumab (1)

gG/US4 (2)

T-cell surface antigen T3/Leu-4 epsilon chain (1)

Pasotuxizumab (1)

TIGIT & CD274/PD-L1 (1)

Cixutumumab (1)

H3L (3)

TAU pT217 (1)

Andecaliximab (1)

Alirocumab (1)

Cinpanemab (1)

CD274/PD-L1 & CD28 (1)

TYR/Tyrosinase (2)

Trastuzumab (2)

Nirsevimab (1)

Anifrolumab (1)

S100a15a (1)

CD152/CTLA4 & CD134/OX40 (1)

CD274/PD-L1 & CD137/TNFRSF9 (1)

S100A12 (1)

S100A14 (1)

CD274/PD-L1 (81)

Zanidatamab (1)

Palivizumab (3)

KITLG/SCF (1)

Afutuzumab (1)

sCD14 (1)

CD366/TIM-3 (34)

Spike glycoprotein E1 (2)

Spike glycoprotein (10)

Crizanlizumab (1)

CD340/ERBB2 (1)

Codrituzumab (1)

Tanezumab (1)

Vunakizumab (1)

Tosatoxumab (1)

SOX10 (3)

RBD (Beta) (1)

Meplazumab (1)

Balstilimab (1)

Namilumab (1)

Dilpacimab (1)

Tilavonemab (1)

Natalizumab (2)

S100A8 (3)

Vibecotamab (1)

Zalifrelimab (1)

gB/Envelope glycoprotein B (1)

T-cell surface glycoprotein CD3 epsilon chain (1)

Rosopatamab (2)

Infliximab (2)

Frovocimab (1)

Dalotuzumab (1)

E8L (5)

S100A2 (1)

Depatuxizumab (1)

Retatrutide (1)

CD223/LAG3 & CD279/PD-1 (4)

S100A13 (1)

S100A4 (3)

CD274/PD-L1 & CD152/CTLA4 (1)

Indatuximab (1)

S100B (9)

CD223/LAG3 (41)

CD279/PD-1 & CD274/PD-L1 (1)

CD137/4-1BB & CD274/PD-L1 & ROR1 & CD3 (1)

S100A1 (2)

Vofatamab (1)
Especies

0 seleccionado

Human (178)

Felis catus (Cat) (9)

Cat (1)

Mouse (27)

Canis lupus familiaris (1)

Rat (1)

Neosartorya fumigata (1)

Tupaia chinensis (12)

Mus musculus (Mouse) (7)

Canis lupus familiaris (Dog) (8)

Homo sapiens (Human) (7)

Dog (3)
Aplicaciones

0 seleccionado

IFA (4)

SPR (4)

Bioactivity: FACS (153)

in vivo PD-L1 blockade (3)

IP (2)

in vitro PD-L1 blockade (3)

SDS-PAGE (75)

Bioactivity: FACS (1)

Functional assay (158)

IHC-F (3)

FACS (5)

Inmunógeno (75)

Research in vivo (158)

IF (8)

Functional assay (6)

Bioactivity testing in progress (31)

Research in vivo (4)

Neutralization (2)

Blocking (2)

in vivo CTLA-4 neutralization (2)

ELISA (844)

GICA (2)

IHC (84)

in vivo (2)

in vivo intra-tumoral regulatory T cell depletion (2)

in vivo blockade (2)

Neut (1)

FCM (152)

FuncS (18)

WB (165)

Inhib (1)
Reactividad

0 seleccionado

Dog (13)

Human (198)

Mouse (78)

Cynomolgus monkey (1)

Cyprinus carpio (1)

Callithrix jacchus (1)

Monodelphis domestica (1)

Oryctolagus cuniculus (4)

Pongo abelii (2)

B7-H1 / PD-L1 / CD274 (1)

Rhesus macaque (1)

Mus musculus (Mouse) (1)

Danio rerio (1)

Capra hircus (1)

Oryzias latipes (1)

Drosophila grimshawi (1)

Broad-Spectrum (1)

Xenopus laevis (1)

Macaca mulatta (1)

Bovine (1)

Rat (16)

Drosophila willistoni (1)

Neosartorya fumigata (1)

Homo sapiens (Human) (4)

Monkey (5)

Kirsten murine sarcoma virus (1)

Cat (1)

Kryptolebias marmoratus (1)

Avian retrovirus IC10 (1)

Chicken (4)

Limanda limanda (1)

Avian rous-associated virus type 1 (1)

Carassius auratus (1)

Tupaia chinensis (4)

Pig (6)

Mesocricetus auratus (1)

Bos taurus (8)

Coturnix japonica (1)

Cavia porcellus (1)
Especie huésped

0 seleccionado

Armenian Hamster (5)

Rabbit (61)

Chimeric (5)

Rat (14)

Humanized (34)

Alpaca (6)

HEK293T (1)

Human (157)

Dog (2)

Mouse (164)
Clonalidad

0 seleccionado

Monoclonal (398)

Polyclonal (53)
Conjugado

0 seleccionado

PerCP (28)

Unconjugated (301)

PE (28)

FITC (28)

APC (28)